Thomas Olin
Board Member
Molecular Biology
Kancera
Sweden
Biography
Thomas Olin was born in 1958. CEO of Kancera AB. Ph.D. in physiology and M.Sc. in biology, chemistry and geosciences. Olin has 20 years' experience of both scientific and business management from biotechnology and pharmaceutical companies. He was part of the management group that led the hiving off of Biovitrum from Pharmacia and was later part of the research and business development management at Biovitrum. Olin was responsible for the hiving off of iNovacia from Biovitrum in 2006. He also has extensive experience of the licensing of pharmaceutical development projects
Research Interest
Molecular Biology,Biotechnology,Business Management
